Stay updated on Avelumab Entinostat in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab Entinostat in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision history updated: added revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check47 days agoChange DetectedFallopian tube cancer was added to the conditions list, and the page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now displays Revision: v3.4.1 instead of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedA glossary display option was added, and page metadata was updated to include 'Last Update Submitted that Met QC Criteria,' 'No FEAR Act Data,' and revision note v3.4.0.SummaryDifference0.2%

- Check75 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avelumab Entinostat in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.